Fredrik Ullmann | Venture

Fredrik is CEO at INDICAL Bioscience, a private equity owned diagnostics company in the veterinary and food value chain. INDICAL was carved out from QIAGEN in 2018 and is now operating as a stand alone entity with global operations. Prior to acquiring INDICAL Fredrik lead the the animal nutrition enzymes business at NOVOZYMES for 6 years. From 2008 until 2011 Fredrik was a consultant with Bain & Company in New York focusing on private equity and life sciences. Fredrik has broad management expertise from BD/M&A, Marketing and Sales, Production, R&D with a core in strategy and technology based partnerships. Fredrik got his PhD and Dipl. Ing. MTEC from ETH Zurich.